SlideShare a Scribd company logo
adverse drug reaction (ADR)
• Definitions:
• adverse drug reaction (ADR)
• As per WHO, ADR is any response to a drug
that is noxious and unintended is suspected to
be due to a drug and that occurs at normal
doses used in humans for prophylaxis,
diagnosis, or therapy of disease, or for the
modification of physiologic function.
• Adverse drug event (ADE)
• (WHO) defines an ADE as “any untoward
medical occurrence that may present during
treatment with a pharmaceutical product but
which does not necessarily have a causal
relationship with this treatment”
Classification Of ADRs
• Based on Type of reaction
• Type A (Augmented) reactions Predictable
• Type B (Bizarre) reactions Unpredictable
• Type C (Chemical/Chronic)
• Type D (Delayed)
• Type E (End of treatment)
• Type F (Unexpected Failure)
Predictable (Type A or Augmented)
reactions
• These reactions can be predicated from
pharmacological properties of the drug
• Caused by exaggerated pharmacologic response
• Dose dependent
• mostly preventable and reversible- Dose reduction
• Low mortality
• E.g.
• Anticoagulant- Bleeding
• B- blocker- Bradycardia
• Prazocin- postural hypotention
Unpredictable (Type B or Bizarre)
reaction
• Uncommon
• Not related to the pharmacologic action of the
drug
• Unpredictable
• more serious and require withdrawal of the drug
• High mortality
• Immunologic reactions: anaphylaxis to penicillin
Type C (Chemical/Chronic)
• Biological characteristics can be predicted
from the chemical structure of the drug
• Eg. paracetamol- Hepatoxicity
Type D (Delayed)
• Occurs after many year of treatment
• Can be due to accumulation.
• E.g:
• Chemotherapy- Secondary Tumors
• Antipsychotics: tardive diskinesia
Type E (End of treatment)
• Occurs on withdrawal especially when drug is
stopped suddenly
• Phenytoin withdrawal: Seizure
Classification Of ADRs
• Based on Severity of adverse drug reactions
• Minor: No therapy, antidote or prolongation of
hospitalization is required.
• Moderate: Requires change in drug therapy, specific
treatment or prolongs hospital stay by atleast 1 day.
• Severe: Potentially life-threatening, causes permanent
damage or requires intensive medical treatment.
• Lethal: Directly or indirectly contributes to death of the
patient.
Photosensitivity
• It is a cutaneous reaction resulting from drug
• induced sensitization of the skin to UV radiation.
• (a) Phototoxic
 Drug or its metabolite accumulates in the skin, absorbs light and undergoes a
photochemical reaction followed by a photobiological reaction
local tissue damage
 erythema, edema, blistering
 fast onset and shorter duration.
e..g. Tetracyclines
• (b) Photoallergic
Drug or its metabolite induces a cell mediated immune response which on
exposure to light of longer wave lengths produces a papular or eczematous
contact dermatitis
persist long after exposure
Drugs involved are sulfonamides, sulfonylureas, chloroquine,
Phototoxic Photoallergic
• Skin reaction occurs minutes
to hours after exposure to
agent and light
• (reddening and swelling)
• Reaction is limited to sun-
exposed skin
• May or may not be itchy
• itchy type reaction occurs 24-
72 hours after exposure to
agent and light
May spread to areas that have
not sun-exposed.
• itchy type reaction
Mutagenicity and Carcinogenicity
• Mutagenicity capacity of a drug to cause
genetic defects
• Carcinogenicity capacity of a drug to cause
cancer
• Oxidation of the drug
• production of reactive intermediates affect
genes and cause structural changes in the
chromosomes
• Gene defect
• Drug/Chemical
• modify DNA
• If that modified DNA sequences code for
factors that regulate cell proliferation/growth
• a tumour (cancer) may be produced
Teratogenicity
• capacity of a drug to cause foetal
abnormalities when administered to the
pregnant mother.
• The thalidomide disaster (1958–61) resulting
in thousands of babies born with phocomelia
(seal like limbs)
• The German drug company
developed and sold the drug.
• sedative or hypnotic
• nausea and morning
sickness in pregnant women
• Thalidomide became an over-
the-counter drug in West
Germany
• 5,000 and 7,000 infants were
born
with phocomelia (malformatio
n of the limbs)
• Throughout the world, about
10,000 cases were reported
• only 50% of the 10,000
survived
Hypersensitivity

More Related Content

What's hot

Pharmacology of General anaesthetic drugs.
Pharmacology of General anaesthetic drugs.Pharmacology of General anaesthetic drugs.
Pharmacology of General anaesthetic drugs.
Manoj Kumar
 
Hemopoietic drugs
Hemopoietic drugsHemopoietic drugs
Hemopoietic drugs
Sanju Kaladharan
 
Morphine toxicity (edited)
Morphine toxicity (edited)Morphine toxicity (edited)
Morphine toxicity (edited)
Joey Tabula
 
Opioid Agonists And Antagonists
Opioid Agonists And AntagonistsOpioid Agonists And Antagonists
Opioid Agonists And AntagonistsDr Shah Murad
 
Atropine substitutes
Atropine substitutesAtropine substitutes
Atropine substitutes
Aaditya Udupa
 
Opioids Drugs
Opioids DrugsOpioids Drugs
Opioids Drugs
Khalid
 
Drugs used to treat peptic ulcer disease
Drugs used to treat peptic ulcer diseaseDrugs used to treat peptic ulcer disease
Drugs used to treat peptic ulcer disease
Pravin Prasad
 
Anti-Parkinsonism drugs Pharmacology
Anti-Parkinsonism drugs PharmacologyAnti-Parkinsonism drugs Pharmacology
Anti-Parkinsonism drugs Pharmacology
Koppala RVS Chaitanya
 
Pituitary and thyroid - pharmacology
Pituitary and thyroid - pharmacologyPituitary and thyroid - pharmacology
Pituitary and thyroid - pharmacology
Areej Abu Hanieh
 
Pharmacology of Opioid analgesics II 2020
Pharmacology of Opioid analgesics II 2020 Pharmacology of Opioid analgesics II 2020
Pharmacology of Opioid analgesics II 2020
sathyanarayanan varadarajan
 
Opioid analgesics
Opioid analgesicsOpioid analgesics
Opioid analgesics
Dr.Kiran A Kantanavar
 
Anesthetics - Pharmacology
Anesthetics - PharmacologyAnesthetics - Pharmacology
Anesthetics - Pharmacology
Areej Abu Hanieh
 
Antihistamines
AntihistaminesAntihistamines
Antihistamines
MrunalAkre
 
Opioid analgesic
Opioid analgesicOpioid analgesic
Opioid analgesic
http://neigrihms.gov.in/
 
Opioid agonists & antagonists
Opioid agonists & antagonistsOpioid agonists & antagonists
Opioid agonists & antagonists
SwaroopaNallabariki
 
Coagulants and anticoagulants
Coagulants and anticoagulantsCoagulants and anticoagulants
Coagulants and anticoagulants
Ankita Bist
 
Pharmacotherapy of shock
Pharmacotherapy of shockPharmacotherapy of shock
Pharmacotherapy of shock
http://neigrihms.gov.in/
 
Mivacurium
MivacuriumMivacurium
Mivacurium
Verdah Sabih
 
Neuromuscular blocking agents
Neuromuscular blocking agentsNeuromuscular blocking agents
Neuromuscular blocking agents
DrJagadish Jena
 
Atracurium Vecuronium Pancuronium
Atracurium Vecuronium PancuroniumAtracurium Vecuronium Pancuronium
Atracurium Vecuronium Pancuronium
Ranjith Thampi
 

What's hot (20)

Pharmacology of General anaesthetic drugs.
Pharmacology of General anaesthetic drugs.Pharmacology of General anaesthetic drugs.
Pharmacology of General anaesthetic drugs.
 
Hemopoietic drugs
Hemopoietic drugsHemopoietic drugs
Hemopoietic drugs
 
Morphine toxicity (edited)
Morphine toxicity (edited)Morphine toxicity (edited)
Morphine toxicity (edited)
 
Opioid Agonists And Antagonists
Opioid Agonists And AntagonistsOpioid Agonists And Antagonists
Opioid Agonists And Antagonists
 
Atropine substitutes
Atropine substitutesAtropine substitutes
Atropine substitutes
 
Opioids Drugs
Opioids DrugsOpioids Drugs
Opioids Drugs
 
Drugs used to treat peptic ulcer disease
Drugs used to treat peptic ulcer diseaseDrugs used to treat peptic ulcer disease
Drugs used to treat peptic ulcer disease
 
Anti-Parkinsonism drugs Pharmacology
Anti-Parkinsonism drugs PharmacologyAnti-Parkinsonism drugs Pharmacology
Anti-Parkinsonism drugs Pharmacology
 
Pituitary and thyroid - pharmacology
Pituitary and thyroid - pharmacologyPituitary and thyroid - pharmacology
Pituitary and thyroid - pharmacology
 
Pharmacology of Opioid analgesics II 2020
Pharmacology of Opioid analgesics II 2020 Pharmacology of Opioid analgesics II 2020
Pharmacology of Opioid analgesics II 2020
 
Opioid analgesics
Opioid analgesicsOpioid analgesics
Opioid analgesics
 
Anesthetics - Pharmacology
Anesthetics - PharmacologyAnesthetics - Pharmacology
Anesthetics - Pharmacology
 
Antihistamines
AntihistaminesAntihistamines
Antihistamines
 
Opioid analgesic
Opioid analgesicOpioid analgesic
Opioid analgesic
 
Opioid agonists & antagonists
Opioid agonists & antagonistsOpioid agonists & antagonists
Opioid agonists & antagonists
 
Coagulants and anticoagulants
Coagulants and anticoagulantsCoagulants and anticoagulants
Coagulants and anticoagulants
 
Pharmacotherapy of shock
Pharmacotherapy of shockPharmacotherapy of shock
Pharmacotherapy of shock
 
Mivacurium
MivacuriumMivacurium
Mivacurium
 
Neuromuscular blocking agents
Neuromuscular blocking agentsNeuromuscular blocking agents
Neuromuscular blocking agents
 
Atracurium Vecuronium Pancuronium
Atracurium Vecuronium PancuroniumAtracurium Vecuronium Pancuronium
Atracurium Vecuronium Pancuronium
 

Similar to Adverse drug reaction.pptx

Adverse drug reactions
Adverse drug reactions Adverse drug reactions
Adverse drug reactions
Faiza Waseem
 
adverse drug reaction.ppt
adverse drug reaction.pptadverse drug reaction.ppt
adverse drug reaction.ppt
madan sigdel
 
ADR-RDP-2023.pdf
ADR-RDP-2023.pdfADR-RDP-2023.pdf
ADR-RDP-2023.pdf
rishi2789
 
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICEAdverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
rishi2789
 
Adverse Drug Reactions (ADR) Introduction.pptx
Adverse Drug Reactions (ADR) Introduction.pptxAdverse Drug Reactions (ADR) Introduction.pptx
Adverse Drug Reactions (ADR) Introduction.pptx
MrSALAJKHARE
 
adr ppt (2).ppt
adr ppt (2).pptadr ppt (2).ppt
adr ppt (2).ppt
sumiaru
 
Adverse Drug Recation.pptx
Adverse Drug Recation.pptxAdverse Drug Recation.pptx
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug effects
Adverse drug effectsAdverse drug effects
Adverse drug effects
Dr. Marya Ahsan
 
Adverse drug interactions
Adverse drug interactionsAdverse drug interactions
Adverse drug interactions
ahsansiddiq2
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
Aravinda Kumar
 
5ee1 adverse drug reaction
5ee1 adverse drug reaction5ee1 adverse drug reaction
5ee1 adverse drug reaction
Amira Badr
 
adr-180630071130.pptx
adr-180630071130.pptxadr-180630071130.pptx
adr-180630071130.pptx
Ashraful Choudhury
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
NAKUL DHORE
 
ADVERSE DRUG REACTION
ADVERSE DRUG REACTIONADVERSE DRUG REACTION
ADVERSE DRUG REACTION
Koppala RVS Chaitanya
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
BikashAdhikari26
 
ADR AND ITS MONITORING
ADR  AND  ITS MONITORING ADR  AND  ITS MONITORING
ADR AND ITS MONITORING
abhishek mondal
 
Adverse drug reaction monitoring
Adverse drug reaction monitoringAdverse drug reaction monitoring
Adverse drug reaction monitoring
Dr. Khushboo Bhojwani
 
ADVERSE EFFECTS OF DRUGS
ADVERSE EFFECTS OF DRUGSADVERSE EFFECTS OF DRUGS
ADVERSE EFFECTS OF DRUGS
SanjogBam
 

Similar to Adverse drug reaction.pptx (20)

Adverse drug reactions
Adverse drug reactions Adverse drug reactions
Adverse drug reactions
 
adverse drug reaction.ppt
adverse drug reaction.pptadverse drug reaction.ppt
adverse drug reaction.ppt
 
ADR-RDP-2023.pdf
ADR-RDP-2023.pdfADR-RDP-2023.pdf
ADR-RDP-2023.pdf
 
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICEAdverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
 
Adverse Drug Reactions (ADR) Introduction.pptx
Adverse Drug Reactions (ADR) Introduction.pptxAdverse Drug Reactions (ADR) Introduction.pptx
Adverse Drug Reactions (ADR) Introduction.pptx
 
adr ppt (2).ppt
adr ppt (2).pptadr ppt (2).ppt
adr ppt (2).ppt
 
Adverse Drug Recation.pptx
Adverse Drug Recation.pptxAdverse Drug Recation.pptx
Adverse Drug Recation.pptx
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
Adverse drug effects
Adverse drug effectsAdverse drug effects
Adverse drug effects
 
Adverse drug interactions
Adverse drug interactionsAdverse drug interactions
Adverse drug interactions
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
5ee1 adverse drug reaction
5ee1 adverse drug reaction5ee1 adverse drug reaction
5ee1 adverse drug reaction
 
adr-180630071130.pptx
adr-180630071130.pptxadr-180630071130.pptx
adr-180630071130.pptx
 
ADR
ADR ADR
ADR
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
ADVERSE DRUG REACTION
ADVERSE DRUG REACTIONADVERSE DRUG REACTION
ADVERSE DRUG REACTION
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
ADR AND ITS MONITORING
ADR  AND  ITS MONITORING ADR  AND  ITS MONITORING
ADR AND ITS MONITORING
 
Adverse drug reaction monitoring
Adverse drug reaction monitoringAdverse drug reaction monitoring
Adverse drug reaction monitoring
 
ADVERSE EFFECTS OF DRUGS
ADVERSE EFFECTS OF DRUGSADVERSE EFFECTS OF DRUGS
ADVERSE EFFECTS OF DRUGS
 

Recently uploaded

Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
JEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questionsJEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questions
ShivajiThube2
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
DhatriParmar
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
kimdan468
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 

Recently uploaded (20)

Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
JEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questionsJEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questions
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 

Adverse drug reaction.pptx

  • 2. • Definitions: • adverse drug reaction (ADR) • As per WHO, ADR is any response to a drug that is noxious and unintended is suspected to be due to a drug and that occurs at normal doses used in humans for prophylaxis, diagnosis, or therapy of disease, or for the modification of physiologic function.
  • 3. • Adverse drug event (ADE) • (WHO) defines an ADE as “any untoward medical occurrence that may present during treatment with a pharmaceutical product but which does not necessarily have a causal relationship with this treatment”
  • 4. Classification Of ADRs • Based on Type of reaction • Type A (Augmented) reactions Predictable • Type B (Bizarre) reactions Unpredictable • Type C (Chemical/Chronic) • Type D (Delayed) • Type E (End of treatment) • Type F (Unexpected Failure)
  • 5. Predictable (Type A or Augmented) reactions • These reactions can be predicated from pharmacological properties of the drug • Caused by exaggerated pharmacologic response • Dose dependent • mostly preventable and reversible- Dose reduction • Low mortality • E.g. • Anticoagulant- Bleeding • B- blocker- Bradycardia • Prazocin- postural hypotention
  • 6. Unpredictable (Type B or Bizarre) reaction • Uncommon • Not related to the pharmacologic action of the drug • Unpredictable • more serious and require withdrawal of the drug • High mortality • Immunologic reactions: anaphylaxis to penicillin
  • 7. Type C (Chemical/Chronic) • Biological characteristics can be predicted from the chemical structure of the drug • Eg. paracetamol- Hepatoxicity
  • 8. Type D (Delayed) • Occurs after many year of treatment • Can be due to accumulation. • E.g: • Chemotherapy- Secondary Tumors • Antipsychotics: tardive diskinesia
  • 9. Type E (End of treatment) • Occurs on withdrawal especially when drug is stopped suddenly • Phenytoin withdrawal: Seizure
  • 10. Classification Of ADRs • Based on Severity of adverse drug reactions • Minor: No therapy, antidote or prolongation of hospitalization is required. • Moderate: Requires change in drug therapy, specific treatment or prolongs hospital stay by atleast 1 day. • Severe: Potentially life-threatening, causes permanent damage or requires intensive medical treatment. • Lethal: Directly or indirectly contributes to death of the patient.
  • 11. Photosensitivity • It is a cutaneous reaction resulting from drug • induced sensitization of the skin to UV radiation. • (a) Phototoxic  Drug or its metabolite accumulates in the skin, absorbs light and undergoes a photochemical reaction followed by a photobiological reaction local tissue damage  erythema, edema, blistering  fast onset and shorter duration. e..g. Tetracyclines • (b) Photoallergic Drug or its metabolite induces a cell mediated immune response which on exposure to light of longer wave lengths produces a papular or eczematous contact dermatitis persist long after exposure Drugs involved are sulfonamides, sulfonylureas, chloroquine,
  • 12. Phototoxic Photoallergic • Skin reaction occurs minutes to hours after exposure to agent and light • (reddening and swelling) • Reaction is limited to sun- exposed skin • May or may not be itchy • itchy type reaction occurs 24- 72 hours after exposure to agent and light May spread to areas that have not sun-exposed. • itchy type reaction
  • 13. Mutagenicity and Carcinogenicity • Mutagenicity capacity of a drug to cause genetic defects • Carcinogenicity capacity of a drug to cause cancer • Oxidation of the drug • production of reactive intermediates affect genes and cause structural changes in the chromosomes • Gene defect
  • 14. • Drug/Chemical • modify DNA • If that modified DNA sequences code for factors that regulate cell proliferation/growth • a tumour (cancer) may be produced
  • 15. Teratogenicity • capacity of a drug to cause foetal abnormalities when administered to the pregnant mother. • The thalidomide disaster (1958–61) resulting in thousands of babies born with phocomelia (seal like limbs)
  • 16. • The German drug company developed and sold the drug. • sedative or hypnotic • nausea and morning sickness in pregnant women • Thalidomide became an over- the-counter drug in West Germany • 5,000 and 7,000 infants were born with phocomelia (malformatio n of the limbs) • Throughout the world, about 10,000 cases were reported • only 50% of the 10,000 survived